During the past decade, Clinique et Maternité Sainte-Elisabeth conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique et Maternité Sainte-Elisabeth" #1 sponsor was "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 4 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Jules Bordet Institute" with 3 trials sponsored, "Arcagy Research" with 1 trials sponsored and "Clovis Oncology, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique et Maternité Sainte-Elisabeth" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator and "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Clinique et Maternité Sainte-Elisabeth" are "Breast Cancer" (5 trials), "Squamous Cell Carcinoma of the Head and Neck" (3 trials), "Ovarian Cancer" (2 trials), "Advanced Chemorefractory Colorectal Adenocarcinoma" (1 trials) and "Bisphosphonate-Associated Osteonecrosis of the Jaw" (1 trials). Many other conditions were trialed in "Clinique et Maternité Sainte-Elisabeth" in a lesser frequency.

Most popular intervention types in "Clinique et Maternité Sainte-Elisabeth" are "Drug" (17 trials), "Other" (5 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (2 trials), "Abiraterone acetate or Enzalutamide or Docetaxel" (1 trials), "Best Supportive Care (BSC)" (1 trials), "CHEMOTHERAPY then HORMONOTHERAPY" (1 trials) and "Cabazitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique et Maternité Sainte-Elisabeth" are 11 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique et Maternité Sainte-Elisabeth". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Clinique et Maternité Sainte-Elisabeth, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique et Maternité Sainte-Elisabeth, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".